Join us at Next-Gen Immuno-Oncology Conference: Feb 8-9
Join us at the MarketsandMarkets Next-Gen Immuno-Oncology Conference in San Diego, CA from February 8-9, 2024! We’re excited to present “BioMice: Preclinical Oncology/Immuno-Oncology Models for Evaluating Novel Therapeutics in Vivo” on February 8th from 2:20 to 3:00 PM PST – you don’t want to miss this session!
Whether you need humanized models, pharmacology services, or are seeking antibody partnerships, we’d love to connect with you to learn more about your research objectives.
Speaking Session
Title: BioMice: Preclinical Oncology/Immuno-Oncology Models for Evaluating Novel Therapeutics in Vivo
Date and Time: Feb 8, 2024, 14:20 – 15:00 PST
Speaker: Jay Zhang, PhD. Sr. Business Development Manager, Biocytogen
- Overview of Biocytogen’s Preclinical Platform and Antibody Licensing Business
- Introduction to the application of humanized mouse models and cell lines in assessing preclinical efficacy, toxicity, and other mechanisms of action for antibody/biologic combination therapies, with case studies provided.
- Highlight the versatility of highly immunodeficient (B-NDG) mice and second-generation B-NDG models with humanized cytokines in evaluating both antibody and cell-based immunotherapies.
The Immuno-Oncology Conference brings together renowned researchers, clinicians, industry leaders, and policy makers to explore the latest advancements and breakthroughs in immuno-oncology. With a focus on next-generation approaches and cutting-edge innovations, the conference provides a platform for networking, knowledge exchange, and collaboration. (Source: MarketsandMarkets Next-Gen Immuno-Oncology Conference )
Event Date: February 8-9, 2024 | Event Location: San Diego, CA
